141 related articles for article (PubMed ID: 38588966)
1. Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis.
Mustafa HJ; Sambatur EV; Pagani G; D'Antonio F; Maisonneuve E; Maurice P; Zwiers C; Verweij JEJT; Flood A; Shamshirsaz AA; Jouannic JM; Khalil A
Am J Obstet Gynecol; 2024 Apr; ():. PubMed ID: 38588966
[TBL] [Abstract][Full Text] [Related]
2. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
[TBL] [Abstract][Full Text] [Related]
5. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
Maisonneuve E; Dugas A; Friszer S; Toly-Ndour C; Cariot L; Dhombres F; Cortey A; Mailloux A; Carbonne B; Jouannic JM
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102119. PubMed ID: 33741541
[TBL] [Abstract][Full Text] [Related]
7. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
8. Selective intrauterine growth restriction without concomitant twin-to-twin transfusion syndrome, natural history, and risk factors for fetal death: A systematic review and meta-analysis.
Mustafa HJ; Javinani A; Heydari MH; Saldaña AV; Rohita DK; Khalil A
Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101105. PubMed ID: 37527736
[TBL] [Abstract][Full Text] [Related]
9. Fetal reduction of triplet pregnancies to twins vs singletons: a meta-analysis of survival and pregnancy outcome.
Hessami K; Evans MI; Nassr AA; Espinoza J; Donepudi RV; Cortes MS; Krispin E; Mostafaei S; Belfort MA; Shamshirsaz AA
Am J Obstet Gynecol; 2022 Sep; 227(3):430-439.e5. PubMed ID: 35351408
[TBL] [Abstract][Full Text] [Related]
10. The rate of decline in fetal hemoglobin following intrauterine blood transfusion in the management of red cell alloimmunization.
O'Riordan SL; Ryan GA; Cathcart B; Hughes H; Higgins S; Fitzgerald J; Corcoran S; Walsh J; Mahony R; Carroll S; McAuliffe FM; McParland P
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():93-96. PubMed ID: 35180513
[TBL] [Abstract][Full Text] [Related]
11. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
12. Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.
Mustafa HJ; Seif K; Javinani A; Aghajani F; Orlinsky R; Alvarez MV; Ryan A; Crimmins S
Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100682. PubMed ID: 35728780
[TBL] [Abstract][Full Text] [Related]
13. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
[TBL] [Abstract][Full Text] [Related]
14. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease.
Hudon L; Moise KJ; Hegemier SE; Hill RM; Moise AA; Smith EO; Carpenter RJ
Am J Obstet Gynecol; 1998 Oct; 179(4):858-63. PubMed ID: 9790359
[TBL] [Abstract][Full Text] [Related]
15. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
16. Clinical decision analysis of elective delivery vs expectant management for pregnant individuals with COVID-19-related acute respiratory distress syndrome.
Resende MHF; Yarnell CJ; D'Souza R; Lapinsky SE; Nam A; Shah V; Whittle W; Wright JK; Naimark DMJ
Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100697. PubMed ID: 35878805
[TBL] [Abstract][Full Text] [Related]
17. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.
Fox C; Martin W; Somerset DA; Thompson PJ; Kilby MD
Fetal Diagn Ther; 2008; 23(2):159-63. PubMed ID: 18046076
[TBL] [Abstract][Full Text] [Related]
18. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
19. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?
Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E
Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759
[TBL] [Abstract][Full Text] [Related]
20. Clinical response to therapeutic plasmapheresis and intravenous immunoglobulin in pregnancies complicated by alloimmunization despite persistently high titers: Report of two cases.
Bahkali N; Alhawsawi E; Althakafi K; Arab K; Rayes A; Badawi MA
Clin Case Rep; 2023 Nov; 11(11):e8209. PubMed ID: 38028069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
